You nominated and our expert judging panels deliberated – and now, we proudly showcase this diversity of talent in The Pathologist’s 2020 Power List.
The FDA has introduced new regulatory frameworks to ease digital medical devices’ transition to market – so why aren’t pathology companies using them?
This year’s International Pathology Day was all about point-of-care testing – so how do the experts think quality can be delivered across the board?
How can we develop laboratory standards and regulations in India to close the gap between the services we offer and the services our patients need?
Jennifer Van Eyk
Remote self-sampling may improve diagnosis and prognosis while reducing costs, but numerous factors must be considered for appropriate implementation
Pharmacogenomic testing can only improve patient care if it’s clinically validated, judiciously applied, and easily understood by healthcare providers
Washing and reusing pipette tips could open the door to a greener and cheaper future for laboratories
The WHO’s Classification of Tumors series is entering its fifth edition – and many accessibility improvements make the latest Blue Books the best yet
Kidney discard rates are higher than ever – but the procurement biopsies that often rule out their use are unreliable and need to be standardized
E. Blair Holladay
Pathologists and laboratory medicine professionals do important work – and advocacy is the key to its continuation.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.